Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,050 | 4,461 | 8,386 | 4,003 | 3,477 |
| Gross Profit | 1,050 | 4,461 | 8,386 | 4,003 | 3,477 |
| Operating Expenses | 111,430 | 46,440 | 41,470 | 30,535 | 20,464 |
| Operating Income | -110,380 | -41,979 | -33,084 | -26,532 | -16,987 |
| Interest Expense | 508 | 835 | 873 | 383 | 326 |
| Other Income | 173 | 941 | 1,254 | 403 | 39 |
| Pre-tax Income | -110,715 | -41,873 | -32,703 | -26,512 | -17,274 |
| Net Income Continuous | -110,715 | -41,873 | -32,703 | -26,512 | -17,274 |
| Net Income | $-110,715 | $-41,873 | $-32,703 | $-26,512 | $-17,274 |
| EPS Basic Total Ops | -31.13 | -20.04 | -16.49 | -20.69 | -422.94 |
| EPS Basic Continuous Ops | -31.13 | -20.04 | -16.56 | -20.65 | -421.79 |
| EPS Diluted Total Ops | -31.13 | -20.04 | -16.49 | -20.69 | -422.94 |
| EPS Diluted Continuous Ops | -31.13 | -20.04 | -16.56 | -20.65 | -421.79 |
| EPS Diluted Before Non-Recurring Items | -11.49 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-109,804 | $-42,123 | $-33,219 | $-26,224 | $-16,646 |